Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.68 -0.01 (-1.97%)
As of: Oct 20, 2026 · 3:57 PM EDT

Bluejay Diagnostics (BJDX) EBIT Margin (2020 - 2022)

Updated

Bluejay Diagnostics (BJDX) posted EBIT Margin of -3741.48% for FY2022.

Analysis

Bluejay Diagnostics (BJDX) EBIT Margin (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn 13.44%
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn 33.60%
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn 18.08%
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn 25.18%
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn 21.65%
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 29.48%
10 Bluejay Diagnostics 1.41 Mn -20.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -797.35%
Mar 31, 2021 -862.07%
Sep 30, 2020 -935.82%
API Access

Bluejay Diagnostics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BJDX&period=max&api_key=YOUR_API_KEY